|
|
|
|
|
|
|
|
|
|
A Breast Cancer Test That Saves Lives
PHOENIX, Nov. 3 /PRNewswire/ -- A healthy 44-year-old woman will celebrate many future birthdays thanks to the efforts of Dr. Keri Sweeten and a new blood test for breast cancer.
Dr. Sweeten, a board-certified gynecologist and Fellow of the American College of Obstetr...
|
|
|
|
|
|
|
Beating Cancer: A Blueprint for Survival
JERICHO, N.Y., Nov. 3 /PRNewswire/ -- In his debut memoir, "No Expiration Dates: A Cancer Patient's Strategies for Survival" (published by iUniverse), Leon Weisman recounts his unique and inspirational battle with lung cancer whil...
|
Curis to Present at Merriman Curhan Ford’s Investor Summit 2009
CAMBRIDGE, Mass. -
Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to
develop next generation targeted small molecule drug candidates for
cancer treatment, today announced that the Company will be presenting at
Merriman Curhan Ford’s Investor Summit at 9:00 a.m. EST on N
|
|
|
Biomoda Awarded New Patent
ALBUQUERQUE, N.M. -
Biomoda, Inc. (OTCBB: BMOD), an Albuquerque-based cancer diagnostics
company, announces that it has received notice of allowance for a U.S.
Patent protecting the proprietary formula for the composition that binds
to cancer cells which is utilized in Biomoda’s screen
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Viriathus Research Issues an Update Report for Viralytics Limited
NEW YORK -
Viriathus Research LLC, an independent research firm, issued an Update
Report today for Viralytics Limited (ASX: VLA) (OTC: VRACY), a
biotechnology company that is developing therapies and drugs for the
treatment of cancer in Australia.
The report provides a
|
|
|
|
|
|
|
IntrinsiQ Expands Executive Team
WALTHAM, Mass. -
IntrinsiQ, the company improving
the quality and understanding of cancer care, today announced that Mike
Raquet has been appointed as the company’s first vice president of
business development. Maria Rugani will take over Raquet&r
|